| CAS: | 1716-12-7 | |
| 分子式: | C10H11NaO2 | |
| 分子量: | 186.19 | |
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||||||||||
| S795131 | MACKLIN | 4-苯基丁酸钠盐 | 10mM in DMSO | 136元/1ml; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||||||||||||||||||||||
| S866882 | MACKLIN | 4-苯基丁酸钠盐 | 98% | 59元/200mg; 72元/1g; 296元/5g; 1065元/25g; 2749元/100g; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||
储存:室温,干燥 状态:白色到灰白色固体 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| O0511 | TCI | Sodium 4-Phenylbutyrate | >98.0%(T)(HPLC) | 980元/1G; 3290元/5G; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||
基本信息
技术规格
物性(参考值)
相关法规
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| 245478 | J&K | Sodium phenylbutyrate | 98%, 一种组蛋白脱乙酰酶抑制剂 | 616元/100MG; 720元/500MG; 1389元/5G; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||
基本信息
产品描述 Sodium Phenylbutyrate是一种转录调节因子,通过调控HDAC活性来改变染色质结构从而发挥作用。 靶点(IC50 & Targe) HDAC 体外研究 Phenylbutyrate是一种公知的HDAC抑制剂,这增加了一些基因的基因转录,并且还发挥治疗作用。Phenylbutyrate显著衰减MPTP诱导的纹状体多巴胺的损失和酪氨酸羟化酶阳性神经元的损失。[1] 在前列腺癌细胞中,Phenylbutyrate衰减凋亡拮抗剂的Bcl-X(L),双链断裂修复的蛋白质的DNA依赖性蛋白激酶,前列腺进展标记caveolin-1和促血管发生血管内皮生长因子的表达。在前列腺癌细胞中,Phenylbutyrate和电离辐射协同作用诱导细胞凋亡。 [2] 体内研究 在转基因G93AALS小鼠中,Phenylbutyrate显著延长生存并改善临床病理和表型。Phenylbutyrate可改善G93A小鼠中组蛋白去乙酰化并诱导核因子-κB(NF-κB的)p50,磷酸化的抑制亚基和β细胞淋巴瘤2(BCL-2)的表达,但降低了细胞色素c的和caspase表达。Phenylbutyrate表现磷酸化的IκB,易位的NF-κB的p50至细胞核,或直接乙酰化的NF-κB的p50。[3] 在亨廷顿氏病(HD)的转基因小鼠模型中,Phenylbutyrate增加脑组蛋白乙酰化并降低组蛋白甲基化水平,由免疫细胞化学和Western印迹评估。在纹状体中,Phenylbutyrate增加泛素-蛋白酶体途径的mRNA并下调凋亡性细胞死亡,活性胱天蛋白酶3的免疫反应性。[4] 参考文献 [1] Gardian G, et al. Neuromolecular Med,?004, 5(3), 235-241. [2] Goh M, et al. Neoplasia,?001, 3(4), 331-338. [3] Ryu H, et al. J Neurochem,?005, 93(5), 1087-1098. [4] Gardian G, et al. J Biol Chem,?005, 280(1), 556-563. 安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| Y0000808 | Sodium phenylbutyrate | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 咨询 | |||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 苯基丁酸钠是一种组蛋白去乙酰化酶抑制剂。 包装 Unit quantity: 5 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| 567616 | Sigma-Aldrich | Sodium 4-Phenylbutyrate-CAS 1716-12-7-Calbiochem | A novel anti-neoplastic agent and transcriptional regulator. | 1047.62元/100 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 An antineoplastic agent that demonstrates potent differentiating capacity in multiple hematopoietic and solid tumor cell lines. Acts as an inducer of tumor cytostasis and differentiation as well as of peroxisomal proliferation. A more effective inhibitor of histone deacetylase and inducer of histone acetylation than its structural analogs including 2- and 3-phenylbutyrate. Acts as a transcriptional regulator and improve the targeting of δF508-CFTR (cystic fibrosis transmembrane regulator) for ubiquitination and degradation by reducing the expression of HSC70 in epithelial cells. Also, reported to increase fetal hemoglobin production in vitro and in vivo. 包装 100 mg in Plastic ampoule 生化/生理作用 Product does not compete with ATP. 警告 Toxicity: Standard Handling (A) 重悬 Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C. 其他说明 Tso, S.C., et al. 2013. Proc. Natl. Acad. Sci. USA110, 9728. 法律信息 CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| SML0309 | Sigma-Aldrich | Sodium phenylbutyrate | ≥98% (HPLC) | 1102.04元/100 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 苯基丁酸钠刺激尿中氮元素排出。它是一种前体药物,经过 β-氧化后形成乙酸苯酯。苯基丁酸钠用于处理尿素循环疾病。它可能和月经失调,闭经和食管和胃的疼痛性粘膜炎有关。 应用 苯基丁酸钠用于作为内质网(ER)压力抑制物,用来研究ER压力在 betatrophin表达中的作用。 包装 100 mg in glass bottle 生化/生理作用 苯基丁酸钠是一种组蛋白去乙酰化酶抑制剂。 特点和优势 该化合物是基因调控研究的特色产品。点击此处以了解更多的基因调控特色产品。想要了解有关生物活性小分子在其他研究领域应用的更多信息,请访问sigma.com/discover-bsm。 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| 1614512 | USP | Sodium phenylbutyrate | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. 生化/生理作用 苯基丁酸钠是一种组蛋白去乙酰化酶抑制剂。 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| 448031 | Fluorochem | Sodium 4-phenylbutanoate | 95% | 264元/250mg; 594元/1g; 1430元/5g; 2376元/10g; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||
基本信息
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||